# Effect of Dexmedetomidine on Stress Study of Pituitrin in Laparoscopic Hysteromyoma Surgery

> **NCT03524950** · PHASE3 · UNKNOWN · sponsor: **Beijing Anzhen Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Hysteromyoma

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT03524950
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2018-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03524950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03524950, "Effect of Dexmedetomidine on Stress Study of Pituitrin in Laparoscopic Hysteromyoma Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03524950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*